Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Express Scripts
Johnson and Johnson
Mallinckrodt
Baxter

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Silicon dioxide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for Silicon dioxide?

Silicon dioxide is an investigational drug.

There have been 7 clinical trials for Silicon dioxide. The most recent clinical trial was a Phase 3 trial, which was initiated on March 1st 2011.

The most common disease conditions in clinical trials are Dentin Sensitivity, Diarrhea, and Hepatitis C. The leading clinical trial sponsors are German Federal Ministry of Education and Research, University of Milan, and UPECLIN HC FM Botucatu Unesp.

There are one hundred and eighty-three US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Silicon dioxide
TitleSponsorPhase
Celiac Disease and Vitamin Status: Evaluation of the Effect of Supplementation With a Probiotic (VIVOMIXX®) in a Cohoort of Celiac PatientsUniversity of MilanPhase 4
Probiotics for Quality of Life in Autism Spectrum DisordersAutism SpeaksPhase 0
Probiotics for Quality of Life in Autism Spectrum DisordersAutism Treatment NetworkPhase 0

See all Silicon dioxide clinical trials

Clinical Trial Summary for Silicon dioxide

Top disease conditions for Silicon dioxide
Top clinical trial sponsors for Silicon dioxide

See all Silicon dioxide clinical trials

US Patents for Silicon dioxide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Silicon dioxide   Start Trial Pesticidal polyhalo alkenoic acid esters FMC Corporation (Philadelphia, PA)   Start Trial
Silicon dioxide   Start Trial Azelastine and its salts used to combat psoriasis Asta Pharma AG (DE)   Start Trial
Silicon dioxide   Start Trial Preparation of 2,2-disubstituted pentane-1,5-diamines BASF Aktiengesellschaft (Ludwigshafen, DE)   Start Trial
Silicon dioxide   Start Trial Process for the preparation of 2-nitro-5-fluoro- or -5-chlorophenol Hoechst Aktiengesellschaft (Frankfurt am Main, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Silicon dioxide

Drugname Country Document Number Estimated Expiration Related US Patent
Silicon dioxide Austria 111735 2009-01-11   Start Trial
Silicon dioxide Austria 113208 2009-01-11   Start Trial
Silicon dioxide Australia 4786290 2009-01-11   Start Trial
Silicon dioxide Australia 618443 2009-01-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
Colorcon
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.